SEC Form D · filed August 14, 2017
Aclaris Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Kacy Rozelle · Los Angeles, CAExecGregory A. Ellis · New York, NYExec · DirectorSteven A. Tullman · MALVERN, PADirectorRichard A. Bierly · MALVERN, PADirectorChristopher Powala · Wayne, PAExecSunil K. Gottipati · Princeton, NJExecStanley R. Westreich · Germantown, MDExec · DirectorFrank Ruffo · MALVERN, PAExecStuart Shanler · MALVERN, PAExecSteven A. Tullman · MALVERN, PADirectorAnand A. Mehra · Malvern, PADirectorRichard A. Bierly · MALVERN, PADirectorChristopher Powala · MALVERN, PAExecChristopher A. Molineaux · Malvern, PADirectorAlbert A. Cha · Malvern, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗